Whitehawk Therapeutics, Inc. (WHWK) Stock Forecast & Price Target
Whitehawk Therapeutics, Inc. · NASDAQ
$3.69-0.02 (-0.54%)
15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 4 firms covering Whitehawk Therapeutics, Inc, 4 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $7.00 to $10.00, a moderate spread. The average target of $8.50 sits 130% above the current $3.69. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 2 to 4 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.27 next quarter toward $-1.10 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 ratings
Moderate Buy
Strong Buy00%
Buy4100%
Hold00%
Sell00%
Strong Sell00%
Based on 4 analysts giving stock ratings to Whitehawk Therapeutics, Inc.
As of Jul, 4 of 4 firms rate WHWK a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
WHWK EPS & revenue forecast
EPS · NEXT QUARTER
$-0.27
Range $-0.32 – $-0.22 · 4 analysts · +5% YoY
Next period, 4 analysts expect Whitehawk Therapeutics, Inc. to earn $-0.27 a share (range $-0.32 – $-0.22), versus $-0.25 a year earlier. Full-year consensus is $-1.11, growing to $-1.10 the year after.
REVENUE · NEXT QUARTER
$-287.5K
Range $-2.3M – $0 · 4 analysts
Revenue is expected to reach $-287.5K (range $-2.3M – $0). Full-year consensus is $-1.1M, rising to $-1.1M next year.
Top analysts covering Whitehawk Therapeutics, Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on WHWK.
#1
RB
Robert Burns
HC Wainwright & Co. · Rank #195
Hold
No targeton WHWK
Overall win rate
38%
+ Follow
#2
Reni J. Benjamin
JMP Securities · Rank #290
Buy
$8.00+116.8% to target
Overall win rate
33%
+ Follow
#3
Jonathan Chang
Leerink Partners
Buy
$9.00+143.9% to target
Coverage
—
+ Follow
#4
YZ
Yuan Zhi
B. Riley Securities
Buy
$10.00+171.0% to target
Coverage
—
+ Follow
#5
Tara Bancroft
TD Cowen
Hold
No targeton WHWK
Coverage
—
+ Follow
WHWK stock forecast FAQ
What is WHWK's average 12-month price target?+
The 4 analysts with a live target average $8.50 for Whitehawk Therapeutics, Inc. over the next 12 months, ranging from a $10.00 high to a $7.00 low.
Is WHWK stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 4 analyst ratings, 4 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for WHWK?+
The Street-high target is $10.00 (B. Riley Securities), and the Street-low is $7.00 (Jones Trading). The average of all 4 active targets is $8.50.
How many Wall Street analysts cover WHWK?+
4 analysts have an active rating on Whitehawk Therapeutics, Inc., and 4 firms carry a live 12-month price target.
Who is the most accurate analyst covering WHWK?+
Among analysts who currently cover WHWK, Robert Burns of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #195). Their current call is Hold.
What is Whitehawk Therapeutics, Inc.'s projected EPS for next quarter?+
The consensus estimate is $-0.27 per share (range $-0.32 – $-0.22) across 4 analysts. Full-year EPS is projected at $-1.11, rising to $-1.10 the following year.
How much revenue is Whitehawk Therapeutics, Inc. expected to report next quarter?+
Consensus revenue is $-287.5K (range $-2.3M – $0). Full-year revenue is projected at $-1.1M, growing to $-1.1M next year.
Have analysts been upgrading or downgrading WHWK lately?+
As of Jul, 4 of 4 firms rate WHWK a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their WHWK calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
